Navigation Links
Kessler Foundation tests Ekso exoskeletal device in 6 patients with traumatic spinal cord injury
Date:12/15/2011

West Orange, NJ. December 14, 2011. Monitored by scientists at Kessler Foundation, six people with traumatic spinal cord injuries tested Ekso, the robotic exoskeleton from Ekso Bionics that enables wheelchair users to stand and walk. The six participated in one week of preliminary testing in October 2011. Five patients have paraplegia and one has quadriplegia; they ranged in age from 27 to 45 and had durations of injury from 4 months to 2 years. This video highlights their experiences: http://www.youtube.com/user/KesslerFoundation#p/u/0/HcSEL4FDAVs

In early 2012, the research team, headed by senior research scientist Gail Forrest, PhD, will commence a clinical study in collaboration with Kessler Institute for Rehabilitation.

The week of preliminary testing provided key information that will guide protocol development, including selection criteria for individuals with spinal cord injury. "We will look at the effects of standing and walking for people with paralysis due to spinal cord injury," said Dr. Forrest. "Whether there are physiologic changes taking place, and what those changes mean in terms of functional improvement." While the study at Kessler will focus on the benefits of Ekso in rehabilitation settings, Ekso Bionics also plans to explore the potential for home and community use.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
2. National Science Foundation makes first awards in Sustainability Research Coordination Program
3. Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection
4. National Science Foundation selects University of Colorado Denver team to study city sustainability
5. 11 women scientists announced as winners of Elsevier Foundation OWSD awards
6. Society of Interventional Radiology Foundation campaign bolstered by covidien pledge
7. Society of Interventional Radiology Foundation welcomes corporate gift from Sirtex Medical
8. The Guy Harvey Ocean Foundation awards research grant to RJ Dunlap Marine Conservation Program
9. BIDMC scientist David J. Friedman, M.D., receives award from Doris Duke Charitable Foundation
10. American Health Assistance Foundation announces latest grants for innovative vision research
11. Parkinsons Disease Foundation announces $1 million for novel studies into Parkinsons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
Breaking Biology Technology: